Insight Molecular Diagnostics Inc. (7OC0)
Munich
Closed
Oct 8, 2026
Day's Range
2.7852 wk Range
2.78Profile - 7OC0 - Insight Molecular Diagnostics Inc.
Profile
Mic Code
XMUN
Sector
Healthcare
Industry
Diagnostics & Research
Employees
55
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic response, and characterize tumor biology. Its current portfolio includes GraftAssure, a blood-based platform for transplanted organ health monitoring, along with oncology assays such as DetermaIO and DetermaCNI. Insight Molecular Diagnostics also supports researchers, pharmaceutical customers, and healthcare systems with molecular diagnostic services and precision medicine solutions. Headquartered in Nashville, Tennessee, the company operates a clinical laboratory that serves U.S. medical and research markets.
Profile Details
Type
Common Stock
Address
2 International Plaza Dr.
City
Nashville
State
TN
Zip
37217
Country
United States
Phone
949 409 7600
Key Executives - 7OC0 - Insight Molecular Diagnostics Inc.
Key executives
Cross Listings - 7OC0 - Insight Molecular Diagnostics Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
